Succession of Splicing Regulatory Elements Determines Cryptic 5΄ss Functionality

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2017 Jan 1

PMID 28039323

Citations 10

Authors

Anna-Lena Brillen

Katrin Schoneweis

Lara Walotka

Linda Hartmann

Lisa Muller

Johannes Ptok

Wolfgang Kaisers

Gereon Poschmann

Kai Stuhler

Emanuele Buratti

Stephan Theiss

Heiner Schaal

Affiliations

Soon will be listed here.

Abstract

A critical step in exon definition is the recognition of a proper splice donor (5΄ss) by the 5' end of U1 snRNA. In the selection of appropriate 5΄ss, cis-acting splicing regulatory elements (SREs) are indispensable. As a model for 5΄ss recognition, we investigated cryptic 5΄ss selection within the human fibrinogen Bβ-chain gene (FGB) exon 7, where we identified several exonic SREs that simultaneously acted on up- and downstream cryptic 5΄ss. In the FGB exon 7 model system, 5΄ss selection iteratively proceeded along an alternating sequence of U1 snRNA binding sites and interleaved SREs which in principle supported different 3' exon ends. Like in a relay race, SREs either suppressed a potential 5΄ss and passed the splicing baton on or splicing actually occurred. From RNA-Seq data, we systematically selected 19 genes containing exons with silent U1 snRNA binding sites competing with nearby highly used 5΄ss. Extensive SRE analysis by different algorithms found authentic 5΄ss significantly more supported by SREs than silent U1 snRNA binding sites, indicating that our concept may permit generalization to a model for 5΄ss selection and 3' exon end definition.

Citing Articles

The Establishment of Artificial RNA Cascade Circuits for Gene Regulation Based on Doxycycline-Induced Pre-mRNA Alternative Splicing.

Dai G, Cheng J, Liu W, Yin X, Zhang Y Int J Mol Sci. 2025; 26(3).

PMID: 39940931 PMC: 11817826. DOI: 10.3390/ijms26031163.

Splicing accuracy varies across human introns, tissues, age and disease.

Garcia-Ruiz S, Zhang D, Gustavsson E, Rocamora-Perez G, Grant-Peters M, Fairbrother-Browne A Nat Commun. 2025; 16(1):1068.

PMID: 39870615 PMC: 11772838. DOI: 10.1038/s41467-024-55607-x.

Generation of Transcript Length Variants and Reprogramming of mRNA Splicing During Atherosclerosis Progression in ApoE-Deficient Mice.

Hueso M, Mallen A, Navarro E Biomedicines. 2025; 12(12.

PMID: 39767610 PMC: 11672872. DOI: 10.3390/biomedicines12122703.

Srsf1 and Elavl1 act antagonistically on neuronal fate choice in the developing neocortex by controlling TrkC receptor isoform expression.

Weber A, Parthasarathy S, Borisova E, Epifanova E, Preussner M, Rusanova A Nucleic Acids Res. 2023; 51(19):10218-10237.

PMID: 37697438 PMC: 10602877. DOI: 10.1093/nar/gkad703.

Secretomics-A Key to a Comprehensive Picture of Unconventional Protein Secretion.

Poschmann G, Bahr J, Schrader J, Stejerean-Todoran I, Bogeski I, Stuhler K Front Cell Dev Biol. 2022; 10:878027.

PMID: 35392176 PMC: 8980719. DOI: 10.3389/fcell.2022.878027.

References

Shen M, Mattox W . Activation and repression functions of an SR splicing regulator depend on exonic versus intronic-binding position. Nucleic Acids Res. 2011; 40(1):428-37. PMC: 3245930. DOI: 10.1093/nar/gkr713. View

Yeakley J, Morfin J, Rosenfeld M, Fu X . A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer. Proc Natl Acad Sci U S A. 1996; 93(15):7582-7. PMC: 38789. DOI: 10.1073/pnas.93.15.7582. View

Will C, Luhrmann R . Spliceosome structure and function. Cold Spring Harb Perspect Biol. 2011; 3(7). PMC: 3119917. DOI: 10.1101/cshperspect.a003707. View

Ke S, Zhang X, Chasin L . Positive selection acting on splicing motifs reflects compensatory evolution. Genome Res. 2008; 18(4):533-43. PMC: 2279241. DOI: 10.1101/gr.070268.107. View

Yeo G, Burge C . Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004; 11(2-3):377-94. DOI: 10.1089/1066527041410418. View

Krawczak M, Thomas N, Hundrieser B, Mort M, Wittig M, Hampe J . Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing. Hum Mutat. 2006; 28(2):150-8. DOI: 10.1002/humu.20400. View

Anczukow O, Akerman M, Clery A, Wu J, Shen C, Shirole N . SRSF1-Regulated Alternative Splicing in Breast Cancer. Mol Cell. 2015; 60(1):105-17. PMC: 4597910. DOI: 10.1016/j.molcel.2015.09.005. View

Lynch K, Maniatis T . Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev. 1996; 10(16):2089-101. DOI: 10.1101/gad.10.16.2089. View

Spena S, Duga S, Asselta R, Malcovati M, Peyvandi F, Tenchini M . Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites. Blood. 2002; 100(13):4478-84. DOI: 10.1182/blood-2002-06-1647. View

10.

Cavaloc Y, Bourgeois C, Kister L, Stevenin J . The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA. 1999; 5(3):468-83. PMC: 1369774. DOI: 10.1017/s1355838299981967. View

11.

Schneider M, Will C, Anokhina M, Tazi J, Urlaub H, Luhrmann R . Exon definition complexes contain the tri-snRNP and can be directly converted into B-like precatalytic splicing complexes. Mol Cell. 2010; 38(2):223-35. DOI: 10.1016/j.molcel.2010.02.027. View

12.

Goren A, Ram O, Amit M, Keren H, Lev-Maor G, Vig I . Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers. Mol Cell. 2006; 22(6):769-781. DOI: 10.1016/j.molcel.2006.05.008. View

13.

Poschmann G, Seyfarth K, Besong Agbo D, Klafki H, Rozman J, Wurst W . High-fat diet induced isoform changes of the Parkinson's disease protein DJ-1. J Proteome Res. 2014; 13(5):2339-51. DOI: 10.1021/pr401157k. View

14.

Llorian M, Schwartz S, Clark T, Hollander D, Tan L, Spellman R . Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat Struct Mol Biol. 2010; 17(9):1114-23. PMC: 2933513. DOI: 10.1038/nsmb.1881. View

15.

Amrein H, Hedley M, Maniatis T . The role of specific protein-RNA and protein-protein interactions in positive and negative control of pre-mRNA splicing by Transformer 2. Cell. 1994; 76(4):735-46. DOI: 10.1016/0092-8674(94)90512-6. View

16.

Daguenet E, Dujardin G, Valcarcel J . The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep. 2015; 16(12):1640-55. PMC: 4693517. DOI: 10.15252/embr.201541116. View

17.

Fairbrother W, Yeh R, Sharp P, Burge C . Predictive identification of exonic splicing enhancers in human genes. Science. 2002; 297(5583):1007-13. DOI: 10.1126/science.1073774. View

18.

Mine M, Brivet M, Touati G, Grabowski P, Abitbol M, Marsac C . Splicing error in E1alpha pyruvate dehydrogenase mRNA caused by novel intronic mutation responsible for lactic acidosis and mental retardation. J Biol Chem. 2003; 278(14):11768-72. DOI: 10.1074/jbc.M211106200. View

19.

Erkelenz S, Theiss S, Otte M, Widera M, Peter J, Schaal H . Genomic HEXploring allows landscaping of novel potential splicing regulatory elements. Nucleic Acids Res. 2014; 42(16):10681-97. PMC: 4176321. DOI: 10.1093/nar/gku736. View

20.

Freund M, Asang C, Kammler S, Konermann C, Krummheuer J, Hipp M . A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res. 2003; 31(23):6963-75. PMC: 290269. DOI: 10.1093/nar/gkg901. View